| A Claims Database Analysis of Dose-Dependency of Metformin and Incidence of Lactic Acidosis in Japanese Patients with Type 2 Diabetes | Diabetes Therapy | 4 hours | save |  |  |  |  |
| Oral Semaglutide Reduces HbA 1c and Body Weight in Patients with Type 2 Diabetes Regardless of Background Glucose-Lowering Medication: PIONEER Subgroup Analyses | Diabetes Therapy | 4 hours | save | | | | |
| Fasting Blood Glucose and 2-h Postprandial Blood Glucose Predict Hypertension: A Report from the REACTION Study | Diabetes Therapy | 4 hours | save | | | | |
| Sodium–Glucose Co-Transporter 2 Inhibitors (SGLT2i) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies | Diabetes Therapy | 4 hours | save | | | | |
| Impact of Age on the Effectiveness and Safety of Insulin Glargine 300 U/mL: Results from the REALI European Pooled Data Analysis | Diabetes Therapy | 4 days | save | | | | |
| The Effects of Dietary Nutrition Intake on Glycemic Variability in Type 1 Diabetes Mellitus Adults | Diabetes Therapy | 4 days | save | | | | |
| Ten-Year Outcomes of Percutaneous Coronary Intervention Versus Coronary Artery Bypass Grafting for Patients with Type 2 Diabetes Mellitus Suffering from Left Main Coronary Disease: A Meta-Analysis | Diabetes Therapy | 4 days | save | | | | |
| Glucagon-Like Peptide 1 Receptor Agonist (GLP1RA) Exposure and Outcomes in Type 2 Diabetes: A Systematic Review of Population-Based Observational Studies | Diabetes Therapy | 4 days | save | | | | |
| Effect of Sitagliptin on Serum Irisin Levels in Patients with Newly Diagnosed Type 2 Diabetes Mellitus | Diabetes Therapy | 4 days | save | | | | |
| Switch-to-Semaglutide Study (STS-Study): a Retrospective Cohort Study | Diabetes Therapy | 12 days | save | | | | |
| A Pragmatic Study of Basal and Mid-Mixture Insulins as Starter Insulins in Chinese Patients With Type 2 Diabetes: Observations From Long-Term, Real-World Experience | Diabetes Therapy | 12 days | save | | | | |
| What is Diabetes Remission? | Diabetes Therapy | 15 days | save | | | | |
| Real-World Effectiveness and Safety of Insulin Glargine 300 U/mL in Patients with T2D Uncontrolled on NPH or Premixed Insulins as Part of Routine Clinical Practice in Bulgaria: ToUPGRADE Study | Diabetes Therapy | 16 days | save | | | | |
| Effects of Increasing Metformin Dose vs Adding/Switching to Dipeptidyl Peptidase-4 Inhibitors on Glycemic Control in Patients with Type 2 Diabetes | Diabetes Therapy | 17 days | save | | | | |
| Outcomes in GLP-1 RA-Experienced Patients Switching to Once-Weekly Semaglutide in a Real-World Setting: The Retrospective, Observational EXPERT Study | Diabetes Therapy | 18 days | save | | | | |
| Efficacy and Safety of Luseogliflozin in Patients with Type 2 Diabetes Complicated by Hepatic Dysfunction: A Single-Site, Single-Arm, Open-Label, Exploratory Trial | Diabetes Therapy | 18 days | save | | | | |
| Empagliflozin Improves Liver Steatosis and Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease and Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled Clinical Trial | Diabetes Therapy | 21 days | save | | | | |
| Glucose Variability is Independently Correlated with Serum Level of Pigment Epithelium-Derived Factor in Type 2 Diabetes | Diabetes Therapy | 21 days | save | | | | |
| Injection Technique Education in Patients with Diabetes Injecting Insulin into Areas of Lipohypertrophy: A Randomized Controlled Trial | Diabetes Therapy | 24 days | save | | | | |
| Real-World Clinical Experience of Semaglutide in Secondary Care Diabetes: A Retrospective Observational Study | Diabetes Therapy | 26 days | save | | | | |
| Delphi-Based Consensus on Treatment Intensification in Type 2 Diabetes Subjects Failing Basal Insulin Supported Oral Treatment: Focus on Basal Insulin + GLP-1 Receptor Agonist Combination Therapies | Diabetes Therapy | 28 days | save | | | | |
| Impact of Intensive Glucose Control on Brain Health: Meta-Analysis of Cumulative Data from 16,584 Patients with Type 2 Diabetes Mellitus | Diabetes Therapy | 29 days | save | | | | |
| Effectiveness and Safety of Switching Rapid-Acting Insulins to Insulin Glulisine in Patients with Diabetes: The Observational IGLU-S Study | Diabetes Therapy | 30 days | save | | | | |
| Effectiveness and Safety of Insulin Glulisine When Initiating Supplementary Prandial Insulin Treatment (SIT) in Insulin-Naïve Patients with Type 2 Diabetes: The Observational IGLU-SIT Study | Diabetes Therapy | 30 days | save | | | | |
| The Position of Gliclazide in the Evolving Landscapes and Disease Continuum of T2DM: A Collaborative Delphi Survey-Based Consensus from India | Diabetes Therapy | 38 days | save | | | | |
| What’s in a Name? Redefining Type 2 Diabetes Remission | Diabetes Therapy | 42 days | save | | | | |
| Effects of Switching from Liraglutide or Dulaglutide to Subcutaneous Semaglutide on Glucose Metabolism and Treatment Satisfaction in Patients with Type 2 Diabetes: Protocol for a Multicenter, Prospective, Randomized, Open-Label, Blinded-Endpoint, Par | Diabetes Therapy | 42 days | save | | | | |
| Skin Autofluorescence in Young Adult Offspring of Women with Type 1 Diabetes: A Cross-Sectional Case–Control Study | Diabetes Therapy | 43 days | save | | | | |
| Baseline HbA1c Level Influences the Effect of Periodontal Therapy on Glycemic Control in People with Type 2 Diabetes and Periodontitis: A Systematic Review on Randomized Controlled Trails | Diabetes Therapy | 44 days | save | | | | |
| Effects of the Once-Weekly DPP4 Inhibitor Omarigliptin on Glycemic Control in Patients with Type 2 Diabetes Mellitus on Maintenance Hemodialysis: A 24-Week Open-Label, Multicenter Randomized Controlled Study | Diabetes Therapy | 46 days | save | | | | |
| Application of Telemedicine in Diabetes Care: The Time is Now | Diabetes Therapy | 46 days | save | | | | |
| Effect of Orally Administered Semaglutide Versus Dulaglutide on Diabetes-Related Quality of Life in Japanese Patients with Type 2 Diabetes: The PIONEER 10 Randomized, Active-Controlled Trial | Diabetes Therapy | 48 days | save | | | | |
| Comparison of Patient-Led and Physician-Led Insulin Titration in Japanese Type 2 Diabetes Mellitus Patients Based on Treatment Distress, Satisfaction, and Self-Efficacy: The COMMIT-Patient Study | Diabetes Therapy | 48 days | save | | | | |
| A Retrospective Analysis of Therapeutic Inertia in Type 2 Diabetes Management Across a Diverse Population of Health Care Organizations in the USA | Diabetes Therapy | 48 days | save | | | | |
| Correction to: The Effects of Mobile-App-Based Low-Carbohydrate Dietary Guidance on Postprandial Hyperglycemia in Adults with Prediabetes | Diabetes Therapy | 48 days | save | | | | |
| Long-Term Efficacy and Safety of Ultra Rapid Lispro (URLi) in Adults with Type 1 Diabetes: The PRONTO-T1D Extension | Diabetes Therapy | 48 days | save | | | | |
| Efficacy, Safety, and Immunogenicity of Insulin Aspart Biosimilar SAR341402 Compared with Originator Insulin Aspart in Adults with Diabetes (GEMELLI 1): A Subgroup Analysis by Prior Type of Mealtime Insulin | Diabetes Therapy | 55 days | save | | | | |
| Evaluating the Cost-Effectiveness of Once-Weekly Semaglutide 1 mg Versus Empagliflozin 25 mg for Treatment of Patients with Type 2 Diabetes in the UK Setting | Diabetes Therapy | 57 days | save | | | | |
| Correction to: Semaglutide: Charting New Horizons in GLP-1 Analogue Outcome Studies | Diabetes Therapy | 58 days | save | | | | |
| New-Onset Diabetes in COVID-19: Time to Frame Its Fearful Symmetry | Diabetes Therapy | 71 days | save | | | | |
| Real-World Effectiveness Analysis of Switching From Liraglutide or Dulaglutide to Semaglutide in Patients With Type 2 Diabetes Mellitus: The Retrospective REALISE-DM Study | Diabetes Therapy | 71 days | save | | | | |
| Individualizing Time-in-Range Goals in Management of Diabetes Mellitus and Role of Insulin: Clinical Insights From a Multinational Panel | Diabetes Therapy | 71 days | save | | | | |
| A Consideration of the Psychological Aspects to Managing Patients with Painful Diabetic Neuropathy: An Insight into Pain Management Services at a Tertiary Centre in the UK | Diabetes Therapy | 71 days | save | | | | |
| Comparative Effectiveness of Switching From First-Generation Basal Insulin to Glargine 300 U/ml or Degludec 100 U/ml in Type 1 Diabetes: The RESTORE-1 Study | Diabetes Therapy | 75 days | save | | | | |
| Linear Projection of Estimated Glomerular Filtration Rate Decline with Canagliflozin and Implications for Dialysis Utilization and Cost in Diabetic Nephropathy | Diabetes Therapy | 79 days | save | | | | |
| Latin American Expert Consensus for Comprehensive Management of Type 2 Diabetes from a Metabolic–Cardio–Renal Perspective for the Primary Care Physician | Diabetes Therapy | 81 days | save | | | | |
| The Role of Tirzepatide, Dual GIP and GLP-1 Receptor Agonist, in the Management of Type 2 Diabetes: The SURPASS Clinical Trials | Diabetes Therapy | 81 days | save | | | | |
| Personality Traits, Metabolic Control and the Use of Insulin Pump Functions in Adults With Type 1 Diabetes: An Observational Single-Visit Study | Diabetes Therapy | 81 days | save | | | | |
| Comparative Efficacy of Dual and Single Initiation of Add-On Oral Antihyperglycemic Agents in Type 2 Diabetes Uncontrolled on Metformin Alone: A Systematic Literature Review and Network Meta-Analysis | Diabetes Therapy | 85 days | save | | | | |
| Insulinization in T2DM with Basal Analogues During COVID-19 Pandemic: Expert Opinion from an Indian Panel | Diabetes Therapy | 85 days | save | | | | |
| | 
report | next » |
| |
